V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005251 | 220002059 | null | null | Curative (C) | 2013-06-12 | 2013-06-26 | AML17 TRIAL | null | N | 220027773 | AML17 TRIAL |
| 220005252 | 220002059 | null | 83.3 | Curative (C) | 2014-06-29 | 2014-06-29 | Trial Unspecified | 01 | N | 220027773 | TRIAL |
| 220005253 | 220002060 | null | 78.8 | Curative (C) | 2015-03-22 | 2015-03-27 | AML17 TRIAL | N | N | 220027776 | AML17 TRIAL |
| 220005254 | 220002061 | 1.74 | 0 | Palliative (P) | 2013-12-30 | 2014-01-04 | CYTARABINE | 02 | N | 220027779 | CYTARABINE |
| 220005255 | 220002061 | null | 0 | null | 2014-11-17 | 2014-11-17 | CYTARABINE | 02 | N | 220027779 | CYTARABINE |
| 220005256 | 220002062 | 1.67 | 72.5 | Curative (C) | 2013-03-20 | 2013-03-20 | Trial Unspecified | 1 | null | 220027785 | TRIAL |
| 220005257 | 220002063 | 1.64 | null | Disease modification (D) | 2017-06-24 | 2017-06-24 | LI-1 TRIAL | Y | N | 220027786 | TRIAL |
| 220005258 | 220002064 | 1.81 | 97.1 | Curative (C) | 2013-01-28 | 2013-02-03 | Trial Unspecified | Y | N | 220027787 | TRIAL |
| 220005259 | 220002064 | 1.74 | 107 | Palliative (P) | 2013-05-11 | 2013-05-18 | AML17 TRIAL | 2 | N | 220027787 | AML17 TRIAL |
| 220005260 | 220002064 | 1.7 | 89.6 | Palliative (P) | null | 2015-05-21 | AML17 TRIAL | N | N | 220027787 | AML17 TRIAL |
| 220005268 | 220002067 | 1.65 | 93.3 | Curative (C) | 2016-08-31 | 2016-08-31 | CYTARABINE | N | N | 220027810 | CYTARABINE |
| 220005269 | 220002067 | 1.63 | 70 | Disease modification (D) | 2014-11-18 | 2014-11-22 | Cytarabine Low Dose | 02 | N | 220027810 | CYTARABINE |
| 220005270 | 220015940 | 1.61 | null | Curative (C) | null | 2014-05-01 | Cytarabine Low Dose | N | null | 220027813 | CYTARABINE |
| 220005271 | 220002068 | 1.8 | 65.9 | Palliative (P) | 2017-09-21 | 2017-09-21 | AML17 TRIAL | N | N | 220027814 | AML17 TRIAL |
| 220005272 | 220002069 | 1.69 | null | null | 2013-03-05 | 2013-03-05 | Cytarabine Low Dose | 99 | N | 220027816 | CYTARABINE |
| 220005273 | 220011106 | 1.86 | null | Palliative (P) | null | 2014-08-11 | CYTARABINE | null | null | 220027818 | CYTARABINE |
| 220005274 | 220011106 | 1.82 | 56.5 | Curative (C) | 2014-09-02 | 2014-09-03 | AML17 TRIAL | 1 | N | 220027818 | AML17 TRIAL |
| 220005275 | 220002070 | 1.53 | 55.5 | Curative (C) | 2017-01-27 | 2017-02-07 | Trial Unspecified | Y | N | 220027823 | TRIAL |
| 220005276 | 220011107 | 1.83 | 64 | Curative (C) | 2013-09-22 | 2013-09-22 | AML17 TRIAL | 2 | N | 220027825 | AML17 TRIAL |
| 220005277 | 220002071 | 1.64 | 73.8 | Not known (9) | 2017-07-14 | 2017-07-14 | AML17 TRIAL | Y | N | 220027826 | AML17 TRIAL |
| 220005278 | 220002071 | 1.62 | 86 | Curative (C) | 2014-01-22 | 2014-01-22 | AML17 TRIAL | N | N | 220027826 | AML17 TRIAL |
| 220005279 | 220002071 | null | 0 | Curative (C) | 2013-04-11 | 2013-04-11 | Cytarabine Low Dose | N | N | 220027826 | CYTARABINE |
| 220005280 | 220002071 | 1.71 | 73.899 | Curative (C) | 2016-05-17 | 2016-05-23 | AML17 TRIAL | N | N | 220027826 | AML17 TRIAL |
| 220005281 | 220002071 | 1.63 | null | Curative (C) | 2015-06-15 | 2015-06-16 | LI-1 TRIAL | 01 | N | 220027826 | TRIAL |
| 220005282 | 220002071 | null | 97.05 | null | 2017-03-10 | 2017-03-19 | AML17 TRIAL | N | N | 220027826 | AML17 TRIAL |
| 220005283 | 220002072 | 1.62 | 69 | Adjuvant (A) | 2014-03-14 | 2014-03-19 | AML17 TRIAL | 01 | N | 220027837 | AML17 TRIAL |
| 220005284 | 220002072 | null | null | Curative (C) | 2017-03-21 | 2017-03-21 | Trial Unspecified | Y | null | 220027837 | TRIAL |
| 220005285 | 220002073 | 0 | 0 | Curative (C) | 2015-06-24 | 2015-06-24 | Cytarabine Low Dose | 2 | N | 220027842 | CYTARABINE |
| 220005286 | 220002073 | 1.55 | 106.1 | null | 2014-05-06 | 2014-05-08 | CYTARABINE | N | N | 220027842 | CYTARABINE |
| 220005287 | 220002074 | 1.61 | 52.8 | Palliative (P) | 2016-07-11 | 2016-07-12 | Cytarabine Low Dose | N | N | 220027845 | CYTARABINE |
| 220005288 | 220011111 | 1.68 | 104 | Palliative (P) | 2014-08-31 | 2014-08-31 | Cytarabine Low Dose | N | N | 220027849 | CYTARABINE |
| 220005289 | 220002075 | 1.8 | null | Curative (C) | 2015-08-02 | 2015-08-03 | Cytarabine Low Dose | N | N | 220027851 | CYTARABINE |
| 220005290 | 220002075 | 1.68 | 98 | null | 2014-11-27 | 2014-11-28 | Cytarabine Low Dose | 02 | N | 220027851 | CYTARABINE |
| 220005291 | 220002075 | 1.82 | null | Palliative (P) | null | 2015-09-20 | Cytarabine Intrathecal (any age) | null | null | 220027851 | CYTARABINE |
| 220005292 | 220002076 | null | 83 | Disease modification (D) | 2016-04-22 | 2016-04-25 | Trial Unspecified | Y | N | 220027857 | TRIAL |
| 220005293 | 220002077 | 1.56 | null | Disease modification (D) | 2016-10-27 | 2016-10-30 | Trial Unspecified | 1 | null | 220027860 | TRIAL |
| 220005294 | 220002077 | 0 | 80.1 | Curative (C) | 2015-12-02 | 2015-12-02 | AML17 TRIAL | Y | N | 220027860 | AML17 TRIAL |
| 220005295 | 220002077 | 1.68 | 51 | Disease modification (D) | 2017-06-19 | 2017-06-21 | Trial Unspecified | Y | null | 220027860 | TRIAL |
| 220005296 | 220002078 | 1.76 | 77.3 | Curative (C) | 2017-09-04 | 2017-09-04 | Trial Unspecified | N | N | 220027864 | TRIAL |
| 220005297 | 220002078 | 1.75 | null | null | 2013-04-05 | 2013-04-05 | CYTARABINE | Y | N | 220027864 | CYTARABINE |
| 220005298 | 220002078 | 1.63 | null | Palliative (P) | 2015-07-18 | 2015-08-09 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220027864 | CYTARABINE |
| 220005299 | 220002078 | 1.83 | null | Not known (9) | 2013-01-04 | 2013-01-07 | AML17 TRIAL | 02 | N | 220027864 | AML17 TRIAL |
| 220005300 | 220002078 | 1.77 | 67.3 | null | 2015-07-09 | 2015-07-10 | CYTARABINE | 02 | N | 220027864 | CYTARABINE |
| 220005301 | 220002078 | null | 71 | Palliative (P) | 2015-06-21 | 2015-06-21 | Cytarabine Low Dose | N | N | 220027864 | CYTARABINE |
| 220005302 | 220021709 | 1.57 | 64.5 | Palliative (P) | 2016-03-31 | 2016-04-02 | Cytarabine Low Dose | 02 | N | 220027871 | CYTARABINE |
| 220005303 | 220021709 | 1.66 | 76.2 | Not known (9) | 2016-07-07 | 2016-07-08 | AML17 TRIAL | 1 | N | 220027871 | AML17 TRIAL |
| 220005304 | 220002079 | 1.84 | null | Curative (C) | null | 2017-04-26 | AML17 TRIAL | N | N | 220027875 | AML17 TRIAL |
| 220005305 | 220011115 | null | null | Palliative (P) | 2013-10-15 | 2013-10-15 | CYTARABINE | N | N | 220027880 | CYTARABINE |
| 220005306 | 220011115 | 1.71 | null | Curative (C) | 2013-09-05 | 2013-10-10 | AML17 TRIAL | Y | N | 220027880 | AML17 TRIAL |
| 220005307 | 220002080 | 1.57 | 109.1 | Palliative (P) | 2014-04-20 | 2014-04-20 | Cytarabine Low Dose | null | null | 220027886 | CYTARABINE |